Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The excretion of virus by 30 children was followed over a period of 28 days after their first vaccination with live oral poliovaccine. The type 1 and type 2 strains were isolated at similar high frequencies throughout this period, while the type 3 strain was not excreted by most children after day 2 post vaccination. Mutations in the 5' non-coding region associated with the attenuated phenotype reverted most rapidly for type 3 and least rapidly for type 1. The data are consistent with different degrees of selection against the attenuating mutations in the three serotypes in the gut, but imply that reversion is required for prolonged excretion. The findings also provide a possible explanation for the reported distribution of the rarely occurring vaccine associated cases between recipients and contacts for the three serotypes. A statistically significant difference was not observed between vaccine from the two main suppliers to the UK market.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These viruses with regained virulence incorporate a number of mutations that increase the structural stability of domV (Contreras et al., 1992, Davis et al., 1977, Dunn et al., 1990).”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Dunn et al., 1990
Citations
Cites
History of Sabin attenuated poliovirus oral live vaccine strains
Sabin, A. B., & Boulger, L. R. (1973) · Journal of Biological Standardization · doi:10.1016/0092-1157(73)90048-6 · Cited by 319
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
Nkowane, B. M. (1987) · JAMA · doi:10.1001/jama.257.10.1335 · Cited by 240
Minor, P. D., John, A., Ferguson, M., & Icenogle, J. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-4-693 · Cited by 203
Self-citationMinor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120
Self-citationIntertypic genomic rearrangements of poliovirus strains in vaccinees
CAMMACK, N., PHILLIPS, A., DUNN, G., PATEL, V, & MINOR, P. (1988) · Virology · doi:10.1016/s0042-6822(88)90113-4 · Cited by 111
Self-citationThe Attenuation Of Poliovirus Neurovirulence
Almond, J. W. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.001101 · Cited by 90
Comparative biochemical studies of type 3 poliovirus
Minor, P. D. (1980) · Journal of Virology · doi:10.1128/jvi.34.1.73-84.1980 · Cited by 79
Self-citationVaccination Against Poliomyelitis with Live Virus Vaccines--7
Dick, G. W. A., Dane, D. S., McAlister, J. J., Briggs, M., Nelson, R., & Field, C. M. B. (1961) · BMJ · doi:10.1136/bmj.2.5247.266 · Cited by 72
PERSISTENCE OF IMMUNITY AFTER ADMINISTRATION OF FORMALIN-TREATED POLIOVIRUS VACCINE
Salk, J. (1960) · The Lancet · doi:10.1016/s0140-6736(60)91791-8 · Cited by 53
Paralytic poliomyelitis in England & Wales, 1970–84
Begg, N. T., Chamberlain, R., & Roebuck, M. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066905 · Cited by 12
Self-citation
Research works printed but not linked: 2
- Assaad F, 1982, The relation between acute persisting spinal paralysis and poliomyelitis vaccine—results of a ten‐year enquiry, Bulletin of the World Health Organization, 60, 231
- WHO, 1969, Evidence on the safety and efficacy of live polimyelitis vaccines currently in use, with special reference to type 3 poliovirus, Bulletin of the World Health Organization, 40, 925
Cited by
Live attenuated vaccines: Historical successes and current challenges
Minor, P. D. (2015) · Virology · doi:10.1016/j.virol.2015.03.032 · Cited by 495
Self-citationHost and virus determinants of picornavirus pathogenesis and tropism
Whitton, J. L., Cornell, C. T., & Feuer, R. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1284 · Cited by 252
Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
The molecular biology of poliovaccines
Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217
Self-citationSutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Vaccines · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160
“This change restores a G z C base pair in domain V, and it is known to occur very rapidly upon replication of the virus in the human gut (8).”
BackgroundSelf-citationGavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Inactivated poliovirus vaccine: Past and present experience
Murdin, A. D., Barreto, L., & Plotkin, S. (1996) · Vaccine · doi:10.1016/0264-410x(95)00211-i · Cited by 135
The Evolutionary Pathway to Virulence of an RNA Virus
Stern, A., Yeh, M. T., Zinger, T., Smith, M., Wright, C., Ling, G., Nielsen, R., Macadam, A., & Andino, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.013 · Cited by 127
“Experimental validation Next generation sequencing of excreted viruses Stool samples were collected from primary vaccinees 14 days after vaccination with trivalent OPV (Dunn et al., 1990) and processed by adding 1g to10mLPBScontaining 1g of glass beads and 1mL chloroform in a 50mL Falcon tube.”
MethodStrategies for the Global Eradication of Poliomyelitis by the Year 2000
Wright, P. F., Kim-Farley, R. J., de Quadros, C. A., Robertson, S. E., Scott, R. M., Ward, N. A., & Henderson, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112193252504 · Cited by 115
Halsey, N. A., Pinto, J. A., Espinosa-Rosales, F. J., Faure-Fontenla, M. A., da Silva, E., Khan, A. J., WEBSTER, A. D. B., Minor, P. D., Dunn, G., Asturias, E. J., et al. (2004) · Europe PMC (PubMed Central) · Cited by 106
Self-citationMacadam, A. I., Pollard, S., Ferguson, G. L., Dunn, G., Skuce, R., Almond, J. W., & Minor, P. D. (1991) · Virology · doi:10.1016/0042-6822(91)90877-e · Cited by 112
Self-citationTebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 106
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
Konopka-Anstadt, J. L., Campagnoli, R., Vincent, A., Shaw, J., Wei, L., Wynn, N. T., Smithee, S. E., Bujaki, E., Te Yeh, M., Laassri, M., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0176-7 · Cited by 96
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Self-citationEffect of different vaccination schedules on excretion of oral poliovirus vaccine strains
Laassri, M., Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., & Chumakov, K. (2005) · The Journal of Infectious Diseases · doi:10.1086/498172 · Cited by 85
Georgescu, M. M., Balanant, J., Macadam, A., Otelea, D., Combiescu, M., Combiescu, A. A., Crainic, R., & Delpeyroux, F. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7758-7768.1997 · Cited by 83
“For the Sabin 1 strain, such mutations are frequently located at positions 480 and 525, which is probably a second-site mutation that restores base pairing with Sabin 1 nucleotide 480 (5, 7, 11, 17, 21, 34, 36, 45, 57).”
BackgroundAnimal and human RNA viruses: genetic variability and ability to overcome vaccines
Villa, T. G., Abril, A. G., Sánchez, S., de Miguel, T., & Sánchez-Pérez, A. (2020) · Archives of Microbiology · doi:10.1007/s00203-020-02040-5 · Cited by 75
Mestecky, J. F., Abraham, R., & Ogra, P. L. O. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-524730-6.50036-1 · Cited by 73
Macadam, A. J., Ferguson, G., Burlison, J., Stone, D., Skuce, R., Almond, J. W., & Minor, P. D. (1992) · Virology · doi:10.1016/0042-6822(92)90565-7 · Cited by 71
Self-citationThe polio-eradication programme and issues of the end game
Minor, P. D. (2011) · Journal of General Virology · doi:10.1099/vir.0.036988-0 · Cited by 76
Self-citationPolio eradication, cessation of vaccination and re-emergence of disease
Minor, P. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro906 · Cited by 69
Self-citationRole of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus
McGoldrick, A., Macadam, A. J., Dunn, G., Rowe, A., Burlison, J., Minor, P. D., Meredith, J., Evans, D. J., & Almond, J. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7601-7605.1995 · Cited by 68
Self-citationPoliomyelitis Eradication--a Dangerous Endgame
Nathanson, N., & Fine, P. (2002) · Science · doi:10.1126/science.1071207 · Cited by 67
Ogra, P. L. O., Faden, H. S., Abraham, R., Duffy, L. C., Sun, M., & Minor, P. D. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.1.191 · Cited by 65
Self-citationA mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating
Tatem, J. M., Weeks-Levy, C., Georgiu, A., DiMichele, S. J., Gorgacz, E. J., Racaniello, V. R., Cano, F. R., & Mento, S. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3194-3197.1992 · Cited by 62
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00035-5 · Cited by 85
Prevalence of vaccine-derived polioviruses in the environment
Yoshida, H., Horie, H., Matsuura, K., Kitamura, T., Hashizume, S., & Miyamura, T. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-1107 · Cited by 56
The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
Andino, R., Kirkegaard, K., Macadam, A. J., Racaniello, V. R., & Rosenfeld, A. B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac426 · Cited by 53
ADAR Editing in Viruses: An Evolutionary Force to Reckon with
Piontkivska, H., Wales-McGrath, B. D., Miyamoto, M. M., & Wayne, M. L. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab240 · Cited by 55
Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan
Yoshida, H., Horie, H., Matsuura, K., & Miyamura, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02868-3 · Cited by 52
Malnou, C. E., Pöyry, T. A. A., Jackson, R. J., & Kean, K. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10617-10626.2002 · Cited by 50
Guillot, S., Oţelea, D., Delpeyroux, F., & Crainic, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90307-7 · Cited by 53
The 5′ noncoding region and virulence of poliovirus vaccine strains
Macadam, A. J., Stone, D. M., Almond, J. W., & Minor, P. D. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90803-6 · Cited by 44
Self-citationShahmahmoodi, S., Parvaneh, N., Burns, C. C., Asghar, H., Mamishi, S., Tabatabaie, H., Chen, Q., Teimourian, S., Gooya, M. M., Esteghamati, A., et al. (2008) · Virus Research · doi:10.1016/j.virusres.2008.07.006 · Cited by 44
Laassri, M., Dragunsky, E., Enterline, J., Eremeeva, T., Ivanova, O., Lottenbach, K., Belshe, R., & Chumakov, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2886-2894.2005 · Cited by 43
Molecular Aspects of Poliovirus Biology with a Special Focus on the Interactions with Nerve Cells
Blondel, B., Duncan, G., Couderc, T., Delpeyroux, F., Pavio, N., & Colbère-Garapin, F. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809113478 · Cited by 63
Mulders, M. N., Reimerink, J. H., Stenvik, M., Alaeddinoglu, I., van der Avoort, H. G., Hovi, T., & Koopmans, M. P. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-907 · Cited by 38
Presence of enteroviruses and reoviruses in the waters of the Italian coast of the Adriatic Sea
Pianetti, A., Baffone, W., Citterio, B., Casaroli, A., Bruscolini, F., & Salvaggio, L. (2000) · Epidemiology and Infection · doi:10.1017/s0950268899004604 · Cited by 36
Pianetti, A., Bruscolini, F., Sabatini, L., & Colantoni, P. (2004) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02352.x · Cited by 35
Poliovirus Vaccines: Molecular Biology and Immune Response
Minor, P. D., & Almond, J. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch30 · Cited by 33
Self-citationEnteroviruses in recreational waters of Northern Ireland
Hughes, M. S., Coyle, P. V., & Connolly, J. H. (1992) · Epidemiology and Infection · doi:10.1017/s0950268800050020 · Cited by 33
Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge
Hunziker, I. P., Harkins, S., Feuer, R., Cornell, C. T., & Whitton, J. L. (2004) · Virology · doi:10.1016/j.virol.2004.09.035 · Cited by 34
Laassri, M., Lottenbach, K. R., Belshe, R. B., Rennels, M. B., Plotkin, S. A., & Chumakov, K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503366 · Cited by 29
Wahid, R., Mercer, L. D., Macadam, A. J., Carlyle, S., Stephens, L., Martín, J. E.-S., Chumakov, K., Laassri, M., Petrovskaya, S. N., Smits, S. L., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00355-y · Cited by 29
Contreras, G., Dimock, K., Furesz, J., Gardell, C., Hazlett, D., Karpinski, K., McCorkle, G., & Wu, L. (1992) · Biologicals · doi:10.1016/s1045-1056(05)80003-x · Cited by 27
Buonagurio, D. A., Coleman, J. W., Patibandla, S. A., Prabhakar, B. S., & Tatem, J. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.2.283-289.1999 · Cited by 29
van der Sanden, S., Pallansch, M. A., van de Kassteele, J., El-Sayed, N., Sutter, R. W., Koopmans, M., & van der Avoort, H. (2009) · Journal of Virology · doi:10.1128/jvi.02388-08 · Cited by 26
Martinez, C. V., Old, M. O., Kwock, D., Khan, S. S., García, J. J., Chan, C. S., Webster, R. L., Halpern, M. S., & Maldonado, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/421703 · Cited by 23
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Wakabayashi, K., Nomoto, A., & Hashizume, S. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10224 · Cited by 24
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 35
Blomqvist, S., Savolainen‐Kopra, C., Paananen, A., Bassioni, L. E., Nasr, E. M. E. M., Firstova, L., Zamiatina, N. A., Kutateladze, T., & Roivainen, M. (2010) · Virus Research · doi:10.1016/j.virusres.2010.05.006 · Cited by 25
Tatem, J. M., Weeks-Levy, C., Mento, S. J., Dimichele, S. J., Georgiu, A. F., Waterfield, W. F., Sheip, B., Costalas, C., Davies, T., Ritchey, M. B., et al. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350206 · Cited by 23
Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
Gumede, N., Muthambi, V., & Schoub, B. D. (2012) · Emerging infectious diseases · doi:10.3201/eid1806.120037 · Cited by 21
Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs
Maheden, K., Todd, B., Gordon, C. J., Tchesnokov, E. P., & Götte, M. (2021) · The Enzymes · doi:10.1016/bs.enz.2021.07.002 · Cited by 20
Jahan, N., Wimmer, E., & Mueller, S. (2011) · Journal of Virology · doi:10.1128/jvi.01804-09 · Cited by 23
Chezzi, C., Dommann, C. J., Blackburn, N. K., Maselesele, E., McAnerney, J., & Schoub, B. D. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00079-6 · Cited by 19
Estimating the Risk of Re-Emergence after Stopping Polio Vaccination
Sasaki, A., Haraguchi, Y., & Yoshida, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00178 · Cited by 19
Mallet, L., Pelloquin, F., Brigaud, M., Caudrelier, P., Bandet, R., Xueref, C., Fuchs, F., Gibelin, N., Goldman, C., Moulin, J.-C., et al. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199705)52:1<97::aid-jmv16>3.0.co;2-y · Cited by 15
Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan
Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Ota, Y., Nakayama, T., Doi, Y., & Hashizume, S. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.1.138-142.2002 · Cited by 15
Transmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks
Kim, J., & Rho, S. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.09.026 · Cited by 14
Portes, S. A. R., da Silva, E. E., Siqueira, M. M., de Filippis, A. M. B., Krawczuk, M. M., & do Nascimento, J. P. (1998) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651998000600001 · Cited by 14
Konz, J., Schofield, T., Carlyle, S., Wahid, R., Ansari, A., Strating, J. R. P. M., Yeh, M. T., Manukyan, H., Smits, S. L., Tritama, E., et al. (2021) · Vaccine X · doi:10.1016/j.jvacx.2021.100102 · Cited by 13
Direct extraction and molecular characterization of enteroviruses genomes from human faecal samples
Bolanaki, E., Kottaridi, C., Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Pratti, A., Levidiotou-Stefanou, S., & Markoulatos, P. (2008) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2007.12.001 · Cited by 18
Rare adverse events associated with oral poliovirus vaccine in Brazil
Friedrich, F. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000600001 · Cited by 14
Hsieh, M.-S., Hsu, C.-W., Tu, L.-L., Chai, K. M., Yu, L.-L., Wu, C.-C., Chen, M., Chiang, C.-Y., Liu, S., Liao, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751883 · Cited by 11
Hellen, C. U. T., & Wimmer, E. (2014) · ASM Press eBooks · doi:10.1128/9781555818326.ch2 · Cited by 11
Liu, Y., Ma, T., Liu, J., Zhao, X., Cheng, Z., Guo, H., Xu, R., & Wang, S. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.979147 · Cited by 9
Jarzabek, Z., Zabicka, J., John, A., Howlett, J., Dunn, G., & Wood, D. J. (1992) · Europe PMC (PubMed Central) · Cited by 8
Self-citationOkonko, I. O., Babalola, E. T., Adedeji, A. O., Onoja, A. B., Ogun, A. A., Nkang, A. O., & Adu, F. D. (2008) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr2008.0012 · Cited by 8
Abortive and Subclinical Poliomyelitis in a Family During the 1992 Epidemic in the Netherlands
Kroon, F. P., Weiland, H. T., van Loon, A. M., & van Furth, R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.454 · Cited by 7
Old, M. O., Martinez, C. V., Kwock, D., García, J. J., Martin, G., Chan, C. S., & Maldonado, Y. (2003) · Journal of Virological Methods · doi:10.1016/s0166-0934(03)00133-2 · Cited by 6
Domingo, E., Escarmís, C., Martínez-Salas, E., Martín‐Hernández, A. M., Mateu, M. G., & Martínez, M. Á. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2928-6_19 · Cited by 5
Aintablian, N., Pratt, R. D., & Sawyer, M. H. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890470204 · Cited by 5
Alirezaie, B., Taqavian, M., Aghaiypour, K., Esna‐Ashari, F., & Shafyi, A. (2011) · Journal of Medical Virology · doi:10.1002/jmv.21804 · Cited by 6
Manukyan, H., Wahid, R., Ansari, A., Tritama, E., Macadam, A. J., Konz, J., Chumakov, K., & Laassri, M. (2022) · Vaccines · doi:10.3390/vaccines10091394 · Cited by 5
Vacunas antipoliomielíticas: VPI frente a VPO
Ruíz-Contreras, J., & Merino, Á. H. (2003) · Anales de Pediatría · Cited by 5
The Waterborne and Foodborne Viral Diseases Related to Reemerging of Poliovirus
Hatib, A., Hassou, N., Benchekroun, M. N., Boussettine, R., Hafid, J. E., Bessi, H., & Ennaji, M. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819400-3.00044-2 · Cited by 4
Prikazský, V., Leroux-Roels, G. G., Damme, P. V., Safary, A., Colau, B., & DUCHENE, M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.002 · Cited by 4
Manukyan, H., Tritama, E., Wahid, R., Konopka‐Anstadt, J. L., Konz, J., Chumakov, K., & Laassri, M. (2023) · Vaccines · doi:10.3390/vaccines11111729 · Cited by 3
Manukyan, H., Petrovskaya, S. N., Chumakov, K., & Laassri, M. (2020) · Vaccines · doi:10.3390/vaccines8010120 · Cited by 3
Manukyan, H., Tritama, E., Wahid, R., Ansari, A., Konz, J., Chumakov, K., & Laassri, M. (2021) · Vaccines · doi:10.3390/vaccines9070688 · Cited by 2
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 7
Poliomielite e seu controle pela imunização
Waldman, E. A. (2019) · Editora FIOCRUZ eBooks · doi:10.7476/9786557080627.0003 · Cited by 1
Opmeer, L., Gazzoli, I., Ballmann, M. Z., Willemsen, M., Voshol, G. P., Grudniewska-Lawton, M., Havenga, M. J. E., Yallop, C., Hamidi, A., Gillissen, G. F., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.01.103 · Cited by 1
Stability of attenuated poliovirus strain genotypes in the human intestinal tract
Minor, P. D., Dunn, G., Almond, J. W., & Macadam, A. J. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9278-8_32 · Cited by 1
Self-citationThe Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex
Cheong, D. H. J., Yi, B., Wong, Y. H., & Chu, J. J. H. (2025) · Medicinal Research Reviews · doi:10.1002/med.22097 · Cited by 1
Effect of Intestinal Microenvironment on Mucosal Immune Response to Viruses
Abraham, R., & Ogra, P. L. O. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-732085-4.50033-3 · Cited by 1
Dynamics of genomic variation in poliovirus in Africa
Chezzi, C. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Lum, G. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.3564 · Cited by 1
Generation of liver tissue-resident memory T cells with novel NKT cell agonists and mRNA vaccines
Ganley, M. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25792368
Prevalence and Genetic Diversity of Human Enteroviruses in the Context of Poliovirus Eradication
van der Sanden, S. (2012) · Rivm Repository (Netherlands National Institute for Public Health and the Environment)
Metadata
- Authors
- Dunn, G., Begg, N. T., Cammack, N., & Minor, P. D.
- Affiliations
- National Institute for Biological Standards and Control (GB)
- Corresponding author
- Minor, Philip D.
- ORCID
- Begg, Norman T.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 1990-10
- Volume
- 32
- Issue
- 2
- Pages
- 92-95
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W2124934598
- Cited by
- 94
- References
- 11
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 2 · 2017: 2 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 4
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medical Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- viral excretion, vaccine-derived poliovirus, poliovirus serotypes, reversion, infants
- MeSH terms
- Cells, Cultured, Child, Preschool, Feces, Humans, Metabolic Clearance Rate, Mutation, Poliovirus Vaccine, Oral, Vaccination, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.